Pantoprazole Sodium
40 mg · Tablet, Delayed Release
- Prescription only
- Proton Pump Inhibitor
- Active substance
- Pantoprazole
- Made by
- HAWAII REPACK, INC.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Pantoprazole Sodium). It describes the substance, not this exact product.
Pantoprazole is a PPI that suppresses the final step in gastric acid production by covalently binding to the (H +, K + )-ATPase enzyme system at the secretory surface of the gastric parietal cell.
This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus.
Pantoprazole is extensively metabolized in the liver through the cytochrome P450 (CYP) system.
After a single oral or intravenous dose of 14 C-labeled pantoprazole to healthy, normal metabolizer subjects, approximately 71% of the dose was excreted in the urine, with 18% excreted in the feces through biliary excretion.
Administration of pantoprazole sodium delayed-release tablets with food may delay its absorption up to 2 hours or longer; however, the C max and the extent of pantoprazole absorption (AUC) are not altered.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-06-05
Safety of the active substance
From the US prescribing label for the same active substance (Pantoprazole Sodium). It describes the substance, not this exact product.
- Pantoprazole sodium is contraindicated in patients with known hypersensitivity to any component of the formulation or any substituted benzimidazole.
- Hypersensitivity reactions may include anaphylaxis, anaphylactic shock, angioedema, bronchospasm, acute tubulointerstitial nephritis, and urticaria [see Warnings and Precautions (5.2), Adverse Reactions (6) ].
- Proton pump inhibitors (PPIs), including pantoprazole sodium, are contraindicated in patients receiving rilpivirine-containing products [see Drug Interactions (7) ].
- Patients with known hypersensitivity to any component of the formulation or to substituted benzimidazoles ( 4 ) Patients receiving rilpivirine-containing products ( 4, 7 )
The most frequently occurring adverse reactions are listed in Table 3.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
Bulgaria8 matching products
European UnionNo exact match for this strength and form
Details
| Made by | HAWAII REPACK, INC. |
|---|---|
| Active substance | Pantoprazole |
| Used in | Digestion, stomach, diabetes and nutrition |
| Strength | 40 mg |
| Form | Tablet, Delayed Release |
| Route | Oral |
| Packs | 10 TABLET, DELAYED RELEASE in 1 BOTTLE · 30 TABLET, DELAYED RELEASE in 1 BOTTLE · 20 TABLET, DELAYED RELEASE in 1 BOTTLE |
| NDC | 85534-0028 |
| NDC | 85534-0061 |
Source: NDC Directory · 2026-09-13 · not reviewed by a clinician
Source: US Food and Drug Administration, NDC Directory. Reuse terms: US government work (FDA).
Other strengths and forms
99 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- Tablet, Delayed Release71 products
- Injection, Powder, Lyophilized, for Solution8 products
40 mg3
40 mg · 3 companies
40 mg/10mL5
- Injection, Powder, for Solution8 products
40 mg3
40 mg · 3 companies
40 mg/10mL5
- Granule, Delayed Release5 products
Show all forms · 7 forms
- Injection, Solution3 products
- For Suspension2 products
40 mg2
40 mg · 2 companies
- Powder, for Solution2 products
40 mg/10mL2
40 mg/10mL · 2 companies
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.